MedPath

Multiparametric Characterization of Colorectal Cancers (METRAD)

Active, not recruiting
Conditions
Colo-rectal Cancer
Registration Number
NCT07000474
Lead Sponsor
University Hospital, Brest
Brief Summary

The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).

Detailed Description

Around 20% of patients with colorectal cancer present with synchronous liver metastases at the time of diagnosis. In recent years, there has been increasing interest in the high-throughput extraction of quantitative data from medical images, a technique known as radiomics. Radiomic analysis can involve both qualitative and quantitative imaging parameters, which may be used independently or integrated into multiparametric prediction models.

This is a multicenter, retrospective study designed to investigate the demographic, clinical, and radiological features, treatment regimens, and outcomes of patients diagnosed with colorectal cancer. The study will involve the collection of anonymized clinical data, including age, sex, diagnosis date, treatment details, results from histopathological and genetic analyses, as well as pre- and post-treatment medical imaging typically performed as part of the management of colorectal cancer patients, along with survival and tumor recurrence data.

PRIMARY EVALUATION CRITERIA Prediction of recurrence/treatment response based on the radiomic model.

SECONDARY EVALUATION CRITERIA The impact of CT scan image acquisition and reconstruction parameters on the prognostic model.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients who have undergone surgery for colorectal cancer.

Exclusion Criteria
  • Patients under legal protection (guardianship, curatorship, etc.)
  • Refusal to participate (expressed opposition)
  • Individuals with conditions that could interfere with the study protocol or impact data integrity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
survival predictive model2 years

The primary objective is to evaluate the predictive value of a model built through multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath